<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Vitamin E-valproate neuroprotective therapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/vitamin-e-valproate-neuroprotective-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 05 Nov 2025 13:29:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Vitamin E-valproate neuroprotective therapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Vitamin E Valproate Mitigates Cypermethrin-Induced Seizure Damage</title>
		<link>https://bioengineer.org/vitamin-e-valproate-mitigates-cypermethrin-induced-seizure-damage/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 05 Nov 2025 13:29:23 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antioxidant therapy for neuroinflammation]]></category>
		<category><![CDATA[Cypermethrin-induced seizure mechanisms]]></category>
		<category><![CDATA[environmental neurotoxins and cognitive deficits]]></category>
		<category><![CDATA[oxidative stress mitigation in epilepsy]]></category>
		<category><![CDATA[Vitamin E-valproate neuroprotective therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/vitamin-e-valproate-mitigates-cypermethrin-induced-seizure-damage/</guid>

					<description><![CDATA[Recent research has shed light on the protective effects of Vitamin E when combined with valproate therapy in managing oxidative stress and neuroinflammation exacerbated by Cypermethrin exposure. This study, led by Imam et al., has significant implications for the treatment of epilepsy and seizure disorders, particularly in environments where exposure to neurotoxic substances is a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">291816</post-id>	</item>
	</channel>
</rss>
